SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-020318
Filing Date
2020-08-05
Accepted
2020-08-05 09:19:45
Documents
46
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0620_intecpharmaltd.htm   iXBRL 10-Q 500201
2 CERTIFICATION f10q0620ex31-1_intecpharma.htm EX-31.1 11875
3 CERTIFICATION f10q0620ex31-2_intecpharma.htm EX-31.2 11282
4 CERTIFICATION f10q0620ex32-1_intecpharma.htm EX-32.1 5026
5 CERTIFICATION f10q0620ex32-2_intecpharma.htm EX-32.2 5094
  Complete submission text file 0001213900-20-020318.txt   2679246

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ntec-20200630.xsd EX-101.SCH 29866
7 XBRL CALCULATION FILE ntec-20200630_cal.xml EX-101.CAL 24959
8 XBRL DEFINITION FILE ntec-20200630_def.xml EX-101.DEF 153486
9 XBRL LABEL FILE ntec-20200630_lab.xml EX-101.LAB 274675
10 XBRL PRESENTATION FILE ntec-20200630_pre.xml EX-101.PRE 155868
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0620_intecpharmaltd_htm.xml XML 254140
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37521 | Film No.: 201075912
SIC: 2834 Pharmaceutical Preparations